Background: Previous studies suggest that rifaximin is efficacious in the treatment of hepatic encephalopathy.
Objective: To evaluate the efficacy and safety of rifaximin in addition to lactulose in improving hospitalization outcomes in patients with hepatic encephalopathy.
Methods: Hospital records of patients evaluated for liver transplantation at a single center between January 2006 and May 2008 were reviewed.